Li Xiaomei, Wang Qingyang, Guo Anping, Qiu Yaping, Chen Qiuxia, Li You, Zhang Lanjun, Guo Yaxin, Meng Xiaoyun, Li Shiqian, Liu Guizhi, Zhang Liyun, Liu Jian, Li Xianyang, Cai Longying, Cheng Xuemin, Liu Chuan, Wang Xiaotao, Wood Andrew, Murray James, Liu Guansai, Li Jin, Huang Xiaodong, Dou Dengfeng
HitGen Inc., Chengdu, Sichuan 610200, China.
Vernalis R&D Ltd., Granta Park, Great Abington, Cambridge CB21 6GB, United Kingdom.
ACS Chem Biol. 2025 May 16;20(5):1020-1028. doi: 10.1021/acschembio.4c00833. Epub 2025 Apr 18.
Despite the exciting progress of bifunctional degrader molecules, also known as proteolysis-targeting chimeras (PROTACs), the rapidly expanding field is still significantly hampered by the lack of available E3 ligase ligands. Our research bridges this gap by uncovering a series of small-molecule ligands to the E3 ligase TRIM21 through DNA-Encoded Library (DEL) technology. We confirmed their interaction with TRIM21 using crystallography and demonstrated their antiproliferative effects across various cancer cell types. Furthermore, proteomic studies identified that the mRNA Export Factor GLE1 and the Nuclear Pore Complex Protein NUP155 were significantly downregulated on TRIM21 ligand treatment. This degradation required TRIM21 and was ubiquitin-proteasome-dependent. More specifically, NUP155 was the primary target for the TRIM21 ligands, while GLE1 was considered a passenger target on initial degradation of NUP155. Using immunofluorescence techniques, we further demonstrated that the degradation of GLE1 and NUP155 proteins impaired the integrity of the nuclear envelope, leading to cell death. Highlighted by this research, a novel mode of action has been discovered for the TRIM21 E3 ligase ligand, acting as a monovalent degrader that triggers de novo interaction with functional complex proteins and induces their degradation.
尽管双功能降解分子(也称为蛋白酶靶向嵌合体,即PROTACs)取得了令人兴奋的进展,但这个迅速发展的领域仍然受到可用E3连接酶配体缺乏的严重阻碍。我们的研究通过DNA编码文库(DEL)技术发现了一系列针对E3连接酶TRIM21的小分子配体,从而弥补了这一差距。我们使用晶体学证实了它们与TRIM21的相互作用,并证明了它们对各种癌细胞类型的抗增殖作用。此外,蛋白质组学研究表明,在TRIM21配体处理后,mRNA输出因子GLE1和核孔复合体蛋白NUP155显著下调。这种降解需要TRIM21,并且依赖于泛素-蛋白酶体。更具体地说,NUP155是TRIM21配体的主要靶点,而GLE1在NUP155最初降解时被认为是一个伴随靶点。使用免疫荧光技术,我们进一步证明GLE1和NUP155蛋白的降解损害了核膜的完整性,导致细胞死亡。这项研究突出了TRIM21 E3连接酶配体的一种新作用模式,即作为一种单价降解剂,引发与功能性复合蛋白的从头相互作用并诱导其降解。